– Second funding period “Mechanisms of cardiovascular complications on chronic

   kidney disease”,  SFB/TRR 219 (2022-2025); DFG-Project-ID 322900939

   (Fliser/Jankowski)

– “treatCKD” Novel compounds for the treatment of chronic kidney disease

   (01/2022-31/2024). Grant ID: ANR-21-CE18-0031 (Argiles, Schanstra)

– ERAPERmed  dialysis “Patient-Reported Outcome, Biodata and Process

   Data to Evaluate Dialysis Tolerability”  (October 2020 to 2022)

– EU-ITN “STRATEGY-CKD”  System omics to unravel the                          

  gut-kidney axis in chronic kidney disease (2019-2024)

  European Union’s Horizon 2020, Grant agreement ID:     860329

(Glorieux, Argiles, Burtey, Jankowski, Masereeuw,  Mischak, Perna,

Vlahoua)

– ERA-Permed grant “Kidney Attack”, Multidimensional                               

stratification for treatment of acute kidney injury (2019-2022).

Grant agreement   ID: U1048 (Ortiz, Mischak, Schanstra)

– EU-ITN “CaReSyAn  (2018- 2021) CArdioREnal SYndrome  ANalysis                        

European Union’s Horizon 2020, Grant agreement ID: 764474

(Argiles, Jankowski, Mischak, Schanstra, Stenvinkel, Vlahou)

– SFB TRR 219  (2018 – 2021) “Mechanisms of Cardiovascular

Complications in Chronic Kidney Disease”                                                            

 

– FP7- Health   EU-Mascara  (2011-2016)                                                                                 

  (Fliser, Mischak, Jankowski, Wiecek)